The incidence of sudden cardiac arrest during marathons and half-marathons remained relatively stable over the past 2 decades ...

For patients with atrial fibrillation and obesity, lifestyle modification plus antiarrhythmic drug therapy conferred various ...

The FDA approved Kerendia in July 2021 for adults with chronic kidney disease associated with Type 2 diabetes to reduce the ...

Medtronic plc’s Evolut Low-Risk trial continued to show non-inferiority of transcatheter aortic valve replacement to surgical ...

PET/CT, the first pan-amyloid diagnostic imaging agent, demonstrated 100% sensitivity and specificity for the diagnosis of cardiac amyloidosis in patients suspected or diagnosed with cardiac ...

The follow-up brought little surprise, with investigators pleased the risk of death/disabling stroke remained on par with ...

Tenaya Therapeutics (TNYA) announced that interim data from the first three patients enrolled in the company’s MyPEAK-1 Phase 1b/2 clinical ...

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...

While inconsistent dosing could have played a role, it still may be possible to identify the patients most likely to see ...

Your Step-by-Step Guide to Becoming a Cardiology Nurse Practitioner Cardiology nurse practitioners play a vital role in ...

Sensydia, a clinical-stage non-invasive cardiac assessment company, announced today that University of Minnesota ...

Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing ...